Etelcalcetide controls secondary hyperparathyroidism and raises sclerostin levels in hemodialysis patients previously uncontrolled with cinacalcet Luciano Artur Lopes Pereira; Catarina Meng; Manuel Augusto Gonçalves Amoedo; Maria Teresa de Sousa Costa Pinto Ferreira Mendes; Marco Alexandre Mateus Prazeres Marques; João Miguel Machado Dória Frazão; André Luiz Loureiro Weigert;

Inflammation and hemodialysis adequacy: are C-reactive protein levels influenced by the dose of dialysis? Francisco Valga; Tania Monzón; Nicanor Vega-Diaz; José Carlos Rodriguez-Perez; Sergio Ruiz-Santana;

Diabetes acts on mortality in hemodialysis patients predicted by asymmetric dimethylarginine and inflammation Mauro Sergio Martins Marrocos; Andrei Alkmim Teixeira; Beata Marie Quinto; Maria Eugênia Fernandes Canzian; Silvia Manfredi; Marcelo Costa Batista;